Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
OneSpaWorld
OSW
$2.64B
| $354K | ﹤0.01% |
29,523
+16,547
| +128% | +$180K |
|
2202
Ares Management
ARES
$32.3B
| $353K | ﹤0.01% |
4,237
+28
| +0.7% | +$2.23K |
|
|
MPT
2203
Medical Properties Trust
MPT
$2.4B
| $353K | ﹤0.01% |
42,835
+27
| +0.1% | +$298 |
|
|
CSII
2204
DELISTED
Cardiovascular Systems, Inc.
CSII
| $353K | ﹤0.01% |
+17,756
| New | +$307K |
|
|
MRC
2205
DELISTED
MRC Global
MRC
| $352K | ﹤0.01% |
36,192
+20,335
| +128% | +$231K |
|
2206
Zymeworks
ZYME
$1.73B
| $351K | ﹤0.01% |
+38,894
| New | +$339K |
|
2207
Banc of California
BANC
$3.09B
| $351K | ﹤0.01% |
+28,024
| New | +$453K |
|
2208
Petco
WOOF
$782M
| $349K | ﹤0.01% |
38,777
+21,937
| +130% | +$227K |
|
|
CSR
2209
Centerspace
CSR
$920M
| $349K | ﹤0.01% |
+6,386
| New | +$394K |
|
2210
indie Semiconductor
INDI
$805M
| $348K | ﹤0.01% |
33,011
+17,689
| +115% | +$158K |
|
|
SP
2211
DELISTED
SP Plus Corporation
SP
| $347K | ﹤0.01% |
+10,119
| New | +$359K |
|
2212
Twist Bioscience
TWST
$7.72B
| $346K | ﹤0.01% |
22,933
+13,064
| +132% | +$289K |
|
2213
National Grid
NGG
$80.7B
| $344K | ﹤0.01% |
5,372
| – | – |
|
|
RTL
2214
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $344K | ﹤0.01% |
54,834
+32,573
| +146% | +$211K |
|
2215
Sinclair Inc
SBGI
$989M
| $344K | ﹤0.01% |
+20,015
| New | +$348K |
|
2216
1st Source
SRCE
$2.12B
| $343K | ﹤0.01% |
+7,947
| New | +$388K |
|
2217
Enanta Pharmaceuticals
ENTA
$393M
| $341K | ﹤0.01% |
+8,452
| New | +$404K |
|
2218
Viridian Therapeutics
VRDN
$2.6B
| $341K | ﹤0.01% |
+13,414
| New | +$430K |
|
2219
Oil States International
OIS
$532M
| $341K | ﹤0.01% |
+40,893
| New | +$347K |
|
2220
James River Group Holdings
JRVR
$194M
| $340K | ﹤0.01% |
+16,445
| New | +$362K |
|
|
RWT
2221
Redwood Trust
RWT
$588M
| $339K | ﹤0.01% |
50,298
+27,481
| +120% | +$206K |
|
2222
Scansource
SCSC
$1.05B
| $337K | ﹤0.01% |
+11,087
| New | +$344K |
|
|
AHRT
2223
AH Realty Trust
AHRT
$501M
| $337K | ﹤0.01% |
28,543
+16,452
| +136% | +$202K |
|
2224
Tootsie Roll Industries
TR
$2.97B
| $337K | ﹤0.01% |
+8,198
| New | +$327K |
|
2225
Arcus Biosciences
RCUS
$3.66B
| $334K | ﹤0.01% |
+18,341
| New | +$351K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.